235 related articles for article (PubMed ID: 19899497)
1. Prevention of death in chronic kidney disease: the role of implantable cardioverter defibrillators.
Turner S; Onalan O; Bickle B
CANNT J; 2009; 19(3):29-36; quiz 37-8. PubMed ID: 19899497
[TBL] [Abstract][Full Text] [Related]
2. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis.
Amin MS; Fox AD; Kalahasty G; Shepard RK; Wood MA; Ellenbogen KA
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1275-80. PubMed ID: 18662180
[TBL] [Abstract][Full Text] [Related]
3. Unresolved issues in implantable cardioverter-defibrillator therapy.
Mason PK; DiMarco JP
Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ
Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865
[TBL] [Abstract][Full Text] [Related]
5. Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: an EPGEN substudy.
Williams ES; Shah SH; Piccini JP; Sun AY; Koontz JI; Al-Khatib SM; Hranitzky PM
Europace; 2011 Dec; 13(12):1717-22. PubMed ID: 21821855
[TBL] [Abstract][Full Text] [Related]
6. Do implantable cardioverter defibrillators improve survival in patients with chronic kidney disease at high risk of sudden cardiac death? A meta-analysis of observational studies.
Makki N; Swaminathan PD; Hanmer J; Olshansky B
Europace; 2014 Jan; 16(1):55-62. PubMed ID: 24058182
[TBL] [Abstract][Full Text] [Related]
7. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
Francia P; Cappato R
G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
[No Abstract] [Full Text] [Related]
8. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
9. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death.
Klein MH; Gold MR
Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188
[TBL] [Abstract][Full Text] [Related]
10. Implantable cardioverter defibrillator therapy in chronic kidney disease: a meta-analysis.
Korantzopoulos P; Liu T; Li L; Goudevenos JA; Li G
Europace; 2009 Nov; 11(11):1469-75. PubMed ID: 19812050
[TBL] [Abstract][Full Text] [Related]
11. [Cardiac resynchronization therapy-always with ICD?].
Stellbrink C
Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
[TBL] [Abstract][Full Text] [Related]
12. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death.
Cuculich PS; Sánchez JM; Kerzner R; Greenberg SL; Sengupta J; Chen J; Faddis MN; Gleva MJ; Smith TW; Lindsay BD
Pacing Clin Electrophysiol; 2007 Feb; 30(2):207-13. PubMed ID: 17338717
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
[TBL] [Abstract][Full Text] [Related]
14. Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease.
Bansal N; Szpiro A; Reynolds K; Smith DH; Magid DJ; Gurwitz JH; Masoudi F; Greenlee RT; Tabada GH; Sung SH; Dighe A; Go AS
JAMA Intern Med; 2018 Mar; 178(3):390-398. PubMed ID: 29404570
[TBL] [Abstract][Full Text] [Related]
15. The implantable cardioverter-defibrillator: does everybody need one?
Raj SR; Sheldon RS
Prog Cardiovasc Dis; 2001; 44(3):169-94. PubMed ID: 11727276
[TBL] [Abstract][Full Text] [Related]
16. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
Sinha SK; Mehta D; Gomes JA
Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
[TBL] [Abstract][Full Text] [Related]
17. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
[TBL] [Abstract][Full Text] [Related]
18. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
[TBL] [Abstract][Full Text] [Related]
19. Device therapy in heart failure patients with chronic kidney disease.
Cannizzaro LA; Piccini JP; Patel UD; Hernandez AF
J Am Coll Cardiol; 2011 Aug; 58(9):889-96. PubMed ID: 21851875
[TBL] [Abstract][Full Text] [Related]
20. [Implantable defibrillator. Update].
Maury P; Schläpfer J; Metzger J; Delacrétaz E; Fromer M; Kappenberger L
Rev Med Suisse Romande; 2001 Apr; 121(4):319-25. PubMed ID: 11400406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
